Clinical results of Ocriplasmin versus C3F8 gas for symptomatic Vitreomacular Traction Syndrome

被引：0
|
作者：
Atkins, Katherine [1 ]
Taylor, Simon [1 ]
机构：
[1] Royal Surrey Cty Hosp, Ophthalmol, Guildford, Surrey, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2016年 / 57卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
4049
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Intravitreal Perfluoropropane Gas (C3F8) Versus Ocriplasmin for Vitreomacular Traction (VMT)
    Steinle, Nathan
    Dhoot, Dilsher
    Quezada, Carlos
    Nasir, Ma'an A.
    Pieramici, Dante Joseph
    See, Robert
    Couvillion, Steve
    Castellarin, Alessandro
    Avery, Robert L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [2] Clinical Results of Ocriplasmin For Symptomatic Vitreomacular Traction Syndrome
    Chawla, Anuj
    Fortun, Jorge
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [3] Indications and outcomes for intravitreal injection of C3F8 gas for symptomatic vitreomacular traction
    Josef Guber
    Celine Rusch
    Ivo Guber
    Hendrik P. N. Scholl
    Christophe Valmaggia
    Scientific Reports, 11
  • [4] Indications and outcomes for intravitreal injection of C3F8 gas for symptomatic vitreomacular traction
    Guber, Josef
    Rusch, Celine
    Guber, Ivo
    Scholl, Hendrik P. N.
    Valmaggia, Christophe
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [5] Surgical Results in Ocriplasmin Candidates With Symptomatic Vitreomacular Traction Syndrome
    Vasquez, Dario H.
    Altamirano, Juan C.
    Casaus, Angel
    Del Valle, Rodrigo A.
    Gonzalez, Roberto
    Gonzalez-De la Rosa, Alejandro
    Navarro-Partida, Jose
    Vasquez, Martin A.
    Santos, Arturo
    CURRENT EYE RESEARCH, 2018, 43 (02) : 208 - 212
  • [6] Enzymatic vitreolysis with ocriplasmin for symptomatic vitreomacular traction syndrome
    Gkizis, I.
    Garnavou-Xirou, C.
    Velissaris, S.
    Kabanarou, S.
    Chatziralli, I.
    Kontou, E.
    Xirou, T.
    ACTA OPHTHALMOLOGICA, 2017, 95
  • [7] TREATMENT OF VITREOMACULAR TRACTION WITH INTRAVITREAL PERFLUOROPROPANE (C3F8) INJECTION
    Steinle, Nathan C.
    Dhoot, Dilsher S.
    Ruiz, Carlos Quezada
    Castellarin, Alessandro A.
    Pieramici, Dante J.
    See, Robert F.
    Couvillion, Steven C.
    Nasir, MA'An A.
    Avery, Robert L.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (04): : 643 - 650
  • [8] Effect of intravitreal C3F8 gas in patients with vitreomacular traction A retrospective case series
    Haas, Anna-Maria
    Mayer, Christoph
    Haas, Anton
    Wackernagel, Werner
    SPEKTRUM DER AUGENHEILKUNDE, 2018, 32 (06) : 228 - 238
  • [9] Intravitreal Injection of Expansile Perfluoropropane (C3F8) for the Treatment of Vitreomacular Traction
    Rodrigues, Ian A.
    Stangos, Alexandros N.
    McHugh, Dominic A.
    Jackson, Timothy L.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2013, 155 (02) : 270 - 276
  • [10] Flare changes after intravitreal injection of ocriplasmin in symptomatic vitreomacular traction syndrome
    Pirani, Vittorio
    Pelliccioni, Paolo
    Cesari, Claudia
    Carrozzi, Giulia
    Cavallero, Edoardo
    Mariotti, Cesare
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2019, 63 (03) : 255 - 261
12345